Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 3 studies | 19% ± 4% | |
GABAergic neuron | 3 studies | 43% ± 6% | |
glutamatergic neuron | 3 studies | 55% ± 6% | |
astrocyte | 3 studies | 23% ± 4% | |
oligodendrocyte | 3 studies | 18% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 37% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1505.27 | 2641 / 2642 | 100% | 14.44 | 705 / 705 |
prostate | 100% | 1170.69 | 245 / 245 | 100% | 9.85 | 501 / 502 |
thymus | 100% | 1374.05 | 653 / 653 | 99% | 9.56 | 601 / 605 |
esophagus | 100% | 1250.85 | 1444 / 1445 | 99% | 7.43 | 181 / 183 |
kidney | 100% | 859.08 | 89 / 89 | 98% | 8.61 | 887 / 901 |
ovary | 100% | 1581.47 | 180 / 180 | 98% | 5.91 | 423 / 430 |
adrenal gland | 100% | 1093.26 | 258 / 258 | 98% | 11.98 | 226 / 230 |
breast | 100% | 1268.23 | 459 / 459 | 98% | 10.03 | 1095 / 1118 |
uterus | 100% | 1492.33 | 170 / 170 | 97% | 6.87 | 446 / 459 |
lung | 99% | 925.76 | 575 / 578 | 97% | 6.86 | 1125 / 1155 |
bladder | 100% | 1266.19 | 21 / 21 | 95% | 5.88 | 479 / 504 |
pancreas | 96% | 425.20 | 314 / 328 | 98% | 6.88 | 175 / 178 |
stomach | 100% | 850.16 | 359 / 359 | 93% | 5.60 | 267 / 286 |
intestine | 100% | 1170.93 | 966 / 966 | 93% | 5.26 | 490 / 527 |
skin | 100% | 1243.79 | 1807 / 1809 | 93% | 8.11 | 438 / 472 |
blood vessel | 100% | 1318.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 863.59 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.05 | 1 / 1 |
adipose | 100% | 1197.44 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 737.64 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 845.79 | 846 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 5.40 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 5.95 | 43 / 45 |
liver | 56% | 156.94 | 127 / 226 | 39% | 1.51 | 157 / 406 |
eye | 0% | 0 | 0 / 0 | 71% | 4.29 | 57 / 80 |
peripheral blood | 33% | 411.87 | 302 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006046 | Biological process | N-acetylglucosamine catabolic process |
GO_0006048 | Biological process | UDP-N-acetylglucosamine biosynthetic process |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0006043 | Biological process | glucosamine catabolic process |
GO_0019262 | Biological process | N-acetylneuraminate catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0016853 | Molecular function | isomerase activity |
GO_0004342 | Molecular function | glucosamine-6-phosphate deaminase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GNPDA2 |
Protein name | Glucosamine-6-phosphate isomerase 2 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 2) (GNPDA 2) (GlcN6P deaminase 2) (Glucosamine-6-phosphate isomerase SB52) Glucosamine-6-phosphate deaminase 2 |
Synonyms | GNP2 |
Description | FUNCTION: Catalyzes the reversible conversion of alpha-D-glucosamine 6-phosphate (GlcN-6P) into beta-D-fructose 6-phosphate (Fru-6P) and ammonium ion, a regulatory reaction step in de novo uridine diphosphate-N-acetyl-alpha-D-glucosamine (UDP-GlcNAc) biosynthesis via hexosamine pathway. Deamination is coupled to aldo-keto isomerization mediating the metabolic flux from UDP-GlcNAc toward Fru-6P. At high ammonium level can drive amination and isomerization of Fru-6P toward hexosamines and UDP-GlcNAc synthesis. Has a role in fine tuning the metabolic fluctuations of cytosolic UDP-GlcNAc and their effects on hyaluronan synthesis that occur during tissue remodeling. . |
Accessions | ENST00000295448.8 [Q8TDQ7-1] ENST00000507917.5 [Q8TDQ7-5] ENST00000509756.1 [Q8TDQ7-3] V9GYK3 V9GYW0 ENST00000507534.5 [Q8TDQ7-4] ENST00000609092.5 Q8TDQ7 ENST00000608855.1 |